Anti-phospho-MAP Kinase Kinase 1/2 (pSer217/221) antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution

Code: m7683-.1ml D2-231

Not available outside of the UK & Ireland.

Application

Anti-phospho-MAP Kinase Kinase 1/2 (MEK1/2) has a wide range of applications. The recommended working dilution for immunoblotting in serum treated NIH3T3 cells is...


 Read more

Your Price
$1,103.88 EACH

Not available outside of the UK & Ireland.

Application

Anti-phospho-MAP Kinase Kinase 1/2 (MEK1/2) has a wide range of applications. The recommended working dilution for immunoblotting in serum treated NIH3T3 cells is 1:1000. For immunoprecipitation, a working dilution of 1:50 may be used. For detection by immunohistochemistry in paraffin-embedded human breast carcinoma sections, antibody dilution of 1:100 may be used. For immunocytochemistry (immunofluorescence), in HeLa cells, a working dilution of 1:1000 may be used.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

MAP Kinase Kinase (MAPKK, MEK1 and MEK2) belong to a family of enzymes that activates their substrate by dual phosphorylation at threonine and tyrosine residues. MEK1 and MEK2 have 86% homology in their catalytic domain. Activation of MEK1/2 is mediated in mitogen-stimulated cells by Raf-1 kinase. MEK1/2 then activates ERK1/2 leading to the activation of several downstream targets that contribute to cell proliferation, apoptosis and motility. In addition to ERK1/2, there may be non-catalytic effectors of MEK1/2. MEK isoforms appear to be widely expressed in the central nervous system, thymus, spleen, heart, lung, and kidney. Active forms of MEK1/2 are sufficient for the transformation of NIH3T3 cells of the differentiation of PC-12 cells. The antibody specifically recognizes MEK1/2 (45 kDa) only when phosphorylated at Ser217 and Ser221. It reacts strongly with MEK1/2 phosphorylated only at Ser217, but less when phosphorylated only at Ser221. It shows not cross reaction with any other related family members including SEK.

Immunogen

synthetic phosphopeptide Ser217/221 corresponding to residues around Ser217/221 of human MEK 1/2.

Physical form

Solution in 10 mM HEPES, pH 7.5, containing 150 mM sodium chloride, 100 µg/ml bovine serum albumin and 50% glycerol.

Specificity

Detects MEK 1/2 when phosphorylated at Ser217 and Ser221. It does not react with non-phosphorylated MEK 1/2, SEK (MKK4), MKK3, or MKK6.

antibody formaffinity isolated antibody
antibody product typeprimary antibodies
biological sourcerabbit
clonepolyclonal
conjugateunconjugated
formbuffered aqueous glycerol solution
Gene Informationhuman ... MAPK1(5594)mouse ... Mapk1(26413)rat ... Mapk1(116590)
mol wtantigen 45 kDa
Quality Level200
shipped inwet ice
species reactivityhuman, mouse, rat
storage temp.−20°C
technique(s)flow cytometry: 1:50 using PMA treated human peripheral blood lymphocytes and Jurkat cells., immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100 using tissue sections from human breast carcinoma, immunocytochemistry: 1:1,000 using HeLa cells, immunoprecipitation (IP): 1:50, western blot: 1:1,000 using serum-treated NIH-3T3 cells
UniProt accession no.P28482
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.